Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SAKAR
SAKAR | NSE
629.10
INR-4.55
-0.72%
SAKAR | NSE
Loading StockChartView...
About SAKAR
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
24/04/2026
Close
629.10
Open
635.00
High
637.70
Low
615.00
View Less
SAKAR | NSE
Risk
46.6
Sharpe
2.79
Luna's Score
61/100
Recommendation
Hold
Luna says (SAKAR | NSE)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
What's not Working
Microcap (<300M USD)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
42.2%1 month
46.6%3 months
62.6%6 months
53.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
59.39
Fwd. PE
-
Price to book
2.07
Debt to equity
0.30
Debt to assets
0.20
Ent. to EBITDA
14.52
Ent. to rev.
3.94
PEG
-
Other Fundamentals
EBITDA
402.64M
MarketCap
10.61B
MarketCap(USD)
110.86M
Div. yield
-
Op. margin
13.71
Erngs. growth
-25.30
Rev. growth
5.50
Ret. on equity
5.36
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
71.80
Range1M
152.95
Range3M
270.80
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.36
Price X volume
20.37M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 14.52 | 24.85 | Cheaper |
| Ent. to Revenue | 3.94 | 11.40 | Cheaper |
| PE Ratio | 59.39 | 51.36 | Par |
| Price to Book | 2.07 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 62.55 | 42.17 | Riskier |
| Debt to Equity | 0.30 | 0.35 | Par |
| Debt to Assets | 0.20 | 0.17 | Expensive |
| Market Cap | 10.61B | 290.82B | Emerging |
